4.0 Review

Retromer sorting - A pathogenic pathway in late-onset Alzheimer disease

Journal

ARCHIVES OF NEUROLOGY
Volume 65, Issue 3, Pages 323-328

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneurol.2007.64

Keywords

-

Funding

  1. NATIONAL INSTITUTE ON AGING [R01AG025161, P50AG008702] Funding Source: NIH RePORTER
  2. NIA NIH HHS [AG025161, P50 AG008702, R01 AG025161-04, R01 AG025161-02, R01 AG025161, R01 AG025161-01, R01 AG025161-03] Funding Source: Medline

Ask authors/readers for more resources

During the tail end of the 20th century, a golden period in Alzheimer disease ( AD) research, many of the pathogenic molecules of the autosomal dominant form of the disease were isolated. These molecular defects, however, do not exist in sporadic late-onset AD, the form of the disease that accounts for more than 95% of all cases. Pinpointing the pathogenic molecules of late-onset AD has, therefore, become an urgent goal, both for understanding disease mechanisms and for opening up novel therapeutic avenues. The retromer sorting pathway transports cargo along the endosome-trans-Golgi network, and retromer defects were first implicated in late-onset AD by a study that combined brain imaging with microarray. A range of studies have confirmed that defects in this pathway can play a pathogenic role in the disease. Herein, these findings will be reviewed, the details of the retromer sorting pathway will be discussed, and a biological model that can account for the disease's regional selectivity will be elaborated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available